Sex work as an emerging risk factor for human immunodeficiency virus seroconversion among people who inject drugs in the SurvUDI Network

Sexually Transmitted Diseases

Volumn 43, Issue 10, 2016, Pages 648-655

  Blouin, Karine ^a,b,c   Leclerc, Pascale ^d   Morissette, Carole ^d   Roy, Élise ^a,e   Blanchette, Caty ^c   Parent, Raymond ^a   Serhir, Bouchra ^a   Alary, Michel ^a,b,c  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d Centre Intégré Universitaire de Santé et de Services Sociaux de l'Est de l Île de Montréal Hôpital   (Canada)

^e UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ARTICLE; CONDOM USE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NEEDLE; NONHUMAN; PROSTITUTION; RISK FACTOR; SEROCONVERSION; SEXUAL BEHAVIOR; SYRINGE; BLOOD; IMMUNOLOGY; INCIDENCE; MIDDLE AGED; MULTIVESICULAR BODY; PROPORTIONAL HAZARDS MODEL; QUEBEC; VIROLOGY; YOUNG ADULT;

ADULT; FEMALE; FOLLOW-UP STUDIES; HIV; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; MIDDLE AGED; MULTIVESICULAR BODIES; PROPORTIONAL HAZARDS MODELS; QUEBEC; RISK FACTORS; SEROCONVERSION; SEX WORK; SEXUAL BEHAVIOR; YOUNG ADULT;

EID: 84983041369     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0000000000000504     Document Type: Article

References (35)

1. UNAIDS/WHO working group on global HIV/AIDS and STI surveil-lance. Guidelines for second generation HIV surveillance: an update: Know your epidemic. World Health Organization; 2013.
2. Vickerman P, Martin NK, Roy A, et al. Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission? Drug Alcohol Depend 2013; 132:172-181.
3. Strathdee S. Sexual HIV transmission in the context of injection drug use: implications for interventions. Int J Drug Policy 2003; 14:79-81.
4. Vittinghoff E, Douglas J, Judson F, et al. Per-contact risk of human im-munodeficiency virus transmission between male sexual partners. Am J Epidemiol 1999; 150:306-311.
5. Almeda J, Casabona J, Simon B, et al. Proposed recommendations for the management of HIV post-exposure prophylaxis after sexual, injecting drug or other exposures in Europe. Euro Surveill 2004; 9:35-40.
6. Pinkerton SD, Chesson HW, Crosby RA, et al. Linearity and nonline-arity in HIV/STI transmission: implications for the evaluationof sexual risk reduction interventions. Eval Rev 2011; 35:550-565.
7. Aral SO, Holmes KK. The epidemiology of STIs and their social and behavioral determinants: industrialized and developed countries. In: Sexually Transmitted Diseases 4th. McGraw Hill Medical; 2008: 53-92.
8. Doherty IA. Sexual networks and sexually transmitted infections: in-novations and findings. Curr Opin Infect Dis 2011; 24:70-77.
9. El-Bassel N, Wechsberg WM, Shaw SA. Dual HIV risk and vulnera-bilities among women who use or inject drugs: no single prevention strategy is the answer. Curr Opin HIVAIDS 2012; 7:326-331.
10. Shannon K, Strathdee SA, Goldenberg SM, et al. Global epidemiology of HIV among female sex workers: influence of structural determinants. Lancet 2015; 385:55-71.
11. Gjersing L, Bretteville-Jensen AL. Gender differences in mortality and risk factors in a 13-year cohort study of street-recruited injecting drug users. BMC Public Health 2014; 14:440.
12. Oldenburg CE, Perez-Brumer AG, Reisner SL, et al. Global burden of HIVamong men who engage in transactional sex: a systematic review and meta-analysis. PLoS One 2014; 9 e103549.
13. Roy E, Richer I, Morissette C, et al. Temporal changes in risk factors associated with HIV seroconversion among injection drug users in eastern central Canada. AIDS 2011; 25:1897-1903.
14. Hankins C, Alary M, Parent R, et al. Continuing HIV transmission among injection drug users in Eastern Central Canada: the SurvUDI Study, 1995 to 2000. J Acquir Immune Defic Syndr 2002; 30:514-521.
15. Kerr T, Shannon K, Ti L, et al. Sex work and HIV incidence among people who inject drugs. AIDS 2016; 30:627-634.
16. Kral AH, Bluthenthal RN, Lorvick J, et al. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 2001; 357:1397-1401.
17. Bacon O, Lum P, Hahn J, et al. Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco. Sex Transm Dis 2006; 33:228-234.
18. Rondinelli AJ, Ouellet LJ, Strathdee SA, et al. Young adult injection drug users in the United States continue to practice HIV risk behaviors. Drug Alcohol Depend 2009; 104:167-174.
19. Rosinska M, Sierosławski J, Wiessing L. High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance. BMC Infect Dis 2015; 15:83.
20. DeBeck K, Kerr T, Li K, et al. Smoking of crack cocaineas a risk factor for HIV infection among people who use injection drugs. Can Med Assoc J 2009; 181:585-589.
21. Astemborski J, Vlahov D, Warren D, et al. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. Am J Public Health 1994; 84:382-387.
22. Platt L, Rhodes T, Lowndes CM, et al. Impact of gender and sex work on sexual and injecting risk behaviors and their association with HIV positivity among injecting drug users in an HIV epidemic in Togliatti City, Russian Federation. Sex Transm Dis 2005; 32:605-612.
23. Judd A, Parry J, Hickman M, et al. Evaluation of a modified commer-cial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol 2003; 71:49-55.
24. Tyndall MW, Patrick D, Spittal P, et al. Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control. Sex Transm Infect 2002; 78:i170-i175.
25. Croxford S, Platt L, Hope VD, et al. Sex work amongst people who in-ject drugs in England, Wales and Northern Ireland: findings from a National Surveyof Health Harms and Behaviours. Int J Drug Policy 2015; 26:429-433.
26. O'Connell JM, Lampinen TM, Weber AE, et al. Sexual risk profile of young men in Vancouver, British Columbia, who have sex with men and inject drugs. AIDS Behav 2004; 8:17-23.
27. Kuyper LM, Lampinen TM, Li K, et al. Factors associated with sex trade involvement among male participants in a prospective study of injection drug users. Sex Transm Infect 2004; 80:531-535.
28. Miller CL, Spittal PM, LaLiberte N, et al. Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. J Acquir Immune Defic Syndr 2002; 30:335-341.
29. Paone D, Cooper H, Alperen J, et al. HIV risk behaviours of current sex workers attending syringe exchange: the experiences of women in five US cities. AIDS Care 1999; 11:269-280.
30. Leclerc P, Morissette C, Blanchette C, et al. P114 Sexual behaviours of IDUs: a matter of concern? Can J Infect Dis Med Microbiol 2014; 25:76A.
31. Booth RE, Kwiatkowski CF, Chitwood DD. Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug Alcohol Depend 2000; 58:219-226.
32. Ross MW, Williams ML. Sexual behavior and illicit drug use. Annu Rev Sex Res 2001; 12:290-310.
33. Miller CL, Kerr T, Strathdee SA, et al. Factors associated with prema-ture mortality among young injection drug users in Vancouver. Harm Reduct J 2007; 4:1.
34. Sutton AJ, House T, Hope VD, et al. Modelling HIV in the injecting drug user population and the male homosexual population in a devel-oped country context. Epidemics 2012; 4:48-56.
35. Aral SO, Padian NS, Holmes KK. Advances in multilevel approaches to understanding the epidemiology and prevention of sexually transmitted infections and HIV: an overview. J Infect Dis 2005; 191:S1-S6.